Olanzapine in the treatment of refractory migraine and chronic daily headache

Headache

Volumn 42, Issue 6, 2002, Pages 515-518

  Silberstein, Stephen D ^a   Peres, Mario F P ^b   Hopkins, Mary M ^b   Shechter, Aaron L ^b   Young, William B ^b   Rozen, Todd D ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Atypical neuroleptics; Chronic refractory headache; Olanzapine

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; PIRENZEPINE;

ADULT; AGITATION; AKATHISIA; ARTICLE; BIPOLAR DISORDER; CHRONIC PAIN; CLINICAL ARTICLE; COMORBIDITY; CONSTIPATION; DEPRESSIVE PSYCHOSIS; DISEASE SEVERITY; DRUG EFFICACY; DYSTONIA; EDEMA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HUMAN; MALE; MANIA; MIGRAINE; MYALGIA; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; RATING SCALE; RETROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; TREATMENT FAILURE; TREATMENT OUTCOME; TREMOR; VERTIGO; WEIGHT GAIN; CHRONIC DISEASE; HEADACHE AND FACIAL PAIN; INTRACTABLE PAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIGRAINE DISORDERS; PAIN, INTRACTABLE; PIRENZEPINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036617585     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02126.x     Document Type: Article

References (20)

1. Beasley CM, Dellva MA, Tamura RN, et al. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. Br J Psychiatry. 1999;174:23-30.
2. Glazer WM. Olanzapine and the new generation of antipsychotic agents: patterns of use. J Clin Psychiatry. 1997;58(suppl 10):18-21.
3. Tohen M, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry. 1999;156:702-709.
4. Stamenkovic M, Schindler SD, Aschauer HN, et al. Effective open-label treatment of Tourette's disorder with olanzapine. Int Clin Psychopharmacol. 2000;15:23-28.
5. Schreiber S, Getslev V, Backer MM, Weizman R, Pick CG. The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency. Pharmacol Biochem Behav. 1999;64:75-80.
6. Peroutka SJ. Dopamine and migraine. Neurology. 1997;49:650-656.
7. 2 receptor (DRD2) NcoI alleles. Neurology. 1997;49:201-206.
8. Cerbo R, Barbanti P, Buzzi MG, et al. Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol. 1997;20:36-41.
9. Wang SJ, Silberstein SD, Young WB. Droperidol treatment of status migrainosus and refractory migraine. Headache. 1997;37:377-382.
10. Richman PB, Reischel U, Ostrow A, et al. Droperidol for acute migraine headache. Am J Emerg Med. 1999;17:398-400.
11. Da Costa AR, Monzillo PH, Sanvito WL. Use of chlorpromazine in the treatment of headache at an emergency service [in Portuguese]. Arq Neuropsiquiatr. 1998;56:565-568.
12. Ginder S, Oatman B, Pollack M. A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. J Emerg Med. 2000;18:311-315.
13. Pfaffenrath V, Scherzer S. Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia. 1995;15(suppl 15):14-20.
14. Fisher H. A new approach to emergency department therapy of migraine headache with intravenous haloperidol: a case series. J Emerg Med. 1995;13:119-122.
15. Lucetti C, Nuti A, Pavese N, Gambaccini G, Rossi G, Bonuccelli U. Flunarizine in migraine prophylaxis: predictive factors for a positive response. Cephalalgia. 1998;18:349-352.
16. Silberstein SD. Methysergide. Cephalalgia. 1998;18:421-435.
17. Leone M, Attanasio A, Croci D, et al. The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: a controlled study. Neurology. 2000;55:136-139.
18. Stockton ME, Rasmussen K. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons. Neuropsychopharmacology. 1996;14:97-105.
19. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47:871-875.
20. Sicuteri F. Dopamine, the second putative protagonist in headache. Headache. 1977;17:129-131.